Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
19,544,618
-
Shares change
-
+807,054
-
Total reported value, excl. options
-
$266,200,808
-
Value change
-
+$10,646,750
-
Put/Call ratio
-
95.8%
-
Number of buys
-
43
-
Number of sells
-
-30
-
Price
-
$13.62
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q4 2016
90 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q4 2016.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,544,618 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,865,647 shares), FMR LLC (3,434,964 shares), JPMORGAN CHASE & CO (2,124,601 shares), BlackRock Fund Advisors (1,057,512 shares), PRICE T ROWE ASSOCIATES INC /MD/ (984,543 shares), VANGUARD GROUP INC (901,431 shares), First Eagle Investment Management, LLC (775,254 shares), FRANKLIN RESOURCES INC (651,800 shares), BlackRock Institutional Trust Company, N.A. (513,443 shares), and KENNEDY CAPITAL MANAGEMENT, INC. (478,465 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.